Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
P J StiffR I Fisher

Abstract

To determine the toxicity and prognosis of patients with relapsed and refractory diffuse aggressive non-Hodgkin's lymphoma (NHL) who underwent an autologous bone marrow transplant (ABMT) using augmented preparative regimens, treated in a major cooperative group setting, and to examine prognostic factors for outcome. Ninety-four patients with either chemosensitive (50 patients) or chemoresistant (44 patients) relapse, including 22 who failed induction chemotherapy, were treated with high-dose cyclophosphamide and etoposide with total-body irradiation (TBI) (67 patients) or an augmented carmustine (BCNU), cyclophosphamide, and etoposide (BCV) preparative regimen (27 patients) and an ABMT at 16 Southwest Oncology Group (SWOG) transplant centers. All relapsing patients were required to undergo a minimum of two courses of salvage therapy to determine chemosensitivity before transplant. Overall (OS) and progression-free survival (PFS) were determined and a Cox regression model was used to assess potential prognostic variables. Of the 94 eligible patients, there were 10 (10.6%) deaths before day 50 posttransplant because of infection (six deaths), hemorrhagic alveolitis (three deaths), or bleeding (one death). The median 3-year PFS an...Continue Reading

Citations

Jun 30, 2004·Leukemia & Lymphoma·Margarita TokarOfer Shpilberg
Jan 5, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Patrick J StiffRicardo Spielberger
Feb 21, 2008·European Journal of Haematology·Martin Hutchings, Lena Specht
Jan 19, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A JostingA Engert
Nov 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard I Fisher
Nov 1, 2013·The New England Journal of Medicine·Patrick J StiffRichard I Fisher
Nov 10, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie M VoseJames O Armitage
Apr 24, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Karoline SpaepenLuc Mortelmans
Jun 1, 2009·Expert Review of Hematology·Martin Hutchings
Jan 19, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Brett JansonJames D Mellor
Apr 7, 2007·Nuclear Medicine Communications·Anna M Kirby, N George Mikhaeel
May 30, 2003·Bone Marrow Transplantation·P MolleeJ Lipton
Jun 26, 2007·Bone Marrow Transplantation·H F FernandezH M Lazarus
Mar 12, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradford S HoppeJoachim Yahalom
Jun 25, 2003·Expert Review of Anticancer Therapy·Marcie Tomblyn, Jane N Winter
Feb 22, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ajay K GopalOliver W Press
Feb 28, 2008·Current Opinion in Oncology·Yvette L Kasamon, Richard L Wahl

❮ Previous
Next ❯

Related Concepts

Related Feeds

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
W MillsA H Goldstone
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
H M LazarusD Topolsky
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
J M VoseJ O Armitage
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Jonathan W FriedbergA S Freedman
© 2021 Meta ULC. All rights reserved